Medico Remedies Limited (BOM:540937)
India · Delayed Price · Currency is INR | Market Cap | 3.30B -1.9% |
| Revenue (ttm) | 2.38B +50.0% |
| Net Income | 138.15M +33.7% |
| EPS | 1.66 +33.0% |
| Shares Out | 82.98M |
| PE Ratio | 24.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,058 |
| Open | 39.58 |
| Previous Close | 39.58 |
| Day's Range | 38.77 - 40.10 |
| 52-Week Range | 31.00 - 56.99 |
| Beta | 0.62 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About Medico Remedies
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as antihypertensive, antidiabetics, anti... [Read more]
Financial Performance
In fiscal year 2026, Medico Remedies's revenue was 2.06 billion, an increase of 36.73% compared to the previous year's 1.51 billion. Earnings were 131.15 million, an increase of 29.94%.
Financial StatementsNews
Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government
Shares of Medico Remedies Ltd jumped 4.91% to ₹51.50 in early Tuesday trade after the company announced securing a significant...